Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 94401-94450 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT04822675
REvascularization and Valve Intervention for Ischemic Valve diseasE: REVIVE Trial
NA
Recruiting
80 participants
Started: Aug 12, 2021 · Completed: Aug 31, 2026
2 conditions
1 sponsor
1 location
NCT06278337
X-linked Moesin Associated Immunodeficiency
N/A
Recruiting
16 participants
Started: Aug 12, 2021 · Completed: Jan 12, 2027
4 conditions
1 sponsor
10 locations
NCT04924075
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
PHASE2
Recruiting
322 participants
Started: Aug 12, 2021 · Completed: Jun 4, 2029
5 conditions
1 sponsor
83 locations
NCT05077098
Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer
PHASE1
Active, not recruiting
8 participants
Started: Aug 12, 2021 · Completed: Jul 31, 2028
1 condition
1 sponsor
1 location
NCT05007938
Befotertinib and Icotinib in Treatment-naive Patients With Advanced EGFR-Mutant Lung Cancer
PHASE2
Active, not recruiting
30 participants
Started: Aug 12, 2021 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT04836117
Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study
NA
Recruiting
200 participants
Started: Aug 12, 2021 · Completed: Aug 12, 2025
1 condition
2 sponsors
1 location
NCT04047212
The Link Between Periodontitis, Smoking and Oral Cancer
N/A
Not yet recruiting
200 participants
Started: Aug 12, 2021 · Completed: Jan 30, 2032
2 conditions
1 sponsor
1 location
NCT05867576
Acceptance and Commitment Therapy in Tuberous Sclerosis Complex
NA
Active, not recruiting
15 participants
Started: Aug 12, 2021 · Completed: Mar 30, 2024
1 condition
3 sponsors
1 location
NCT04868604
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
PHASE1/PHASE2
Recruiting
54 participants
Started: Aug 11, 2021 · Completed: Sep 30, 2026
1 condition
1 sponsor
6 locations
NCT06001580
A Phase I Study of BR101 Injection Alone in Subjects With Advanced Solid Tumors
PHASE1
Recruiting
36 participants
Started: Aug 11, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT04954664
Ridge Augmentation Using Allograft Particles Hydrated with or Without Recombinant Human Platelet-Derived Growth Factor
NA
Recruiting
44 participants
Started: Aug 11, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT06692790
VEHICLE Registry: Venous Stenting for IIH in the MENA Region
N/A
Recruiting
150 participants
Started: Aug 11, 2021 · Completed: Nov 11, 2025
1 condition
1 sponsor
2 locations
NCT04629495
Rapamycin - Effects on Alzheimer's and Cognitive Health
PHASE2
Recruiting
40 participants
Started: Aug 11, 2021 · Completed: Mar 31, 2026
2 conditions
2 sponsors
1 location
NCT06147739
Evaluation Treatment Outcomes of Anterior Open Bite Treated by Temporary Anchorage Devices
NA
Enrolling by invitation
10 participants
Started: Aug 11, 2021 · Completed: Dec 20, 2023
1 condition
1 sponsor
1 location
NCT05055804
The ELG Analysis of Glucose a Correlational to Blood Glucose Assay
NA
Enrolling by invitation
100 participants
Started: Aug 11, 2021 · Completed: Nov 30, 2025
2 conditions
1 sponsor
1 location
NCT04710563
SCOPE-CLI: Shifting Care and Outcomes for Patients With Endangered Limbs
N/A
Active, not recruiting
458 participants
Started: Aug 11, 2021 · Completed: Sep 30, 2028
1 condition
14 sponsors
1 location
NCT05046002
COVID-19 Vaccine-induced Inflammatory Heart Disease Prevalence Registry
N/A
Recruiting
400 participants
Started: Aug 11, 2021 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05704361
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
PHASE1
Recruiting
165 participants
Started: Aug 11, 2021 · Completed: Apr 28, 2027
1 condition
1 sponsor
32 locations
NCT05010031
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
PHASE2
Recruiting
29 participants
Started: Aug 11, 2021 · Completed: Aug 31, 2026
1 condition
1 sponsor
7 locations
NCT04663997
177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
PHASE2
Active, not recruiting
200 participants
Started: Aug 11, 2021 · Completed: Dec 31, 2026
1 condition
3 sponsors
10 locations
NCT05018000
Cancer Financial Experience
NA
Active, not recruiting
371 participants
Started: Aug 11, 2021 · Completed: Aug 31, 2025
1 condition
1 sponsor
1 location
NCT04961437
Impact of Dyspnea, Regional Lung Ventilation, and Diaphragmatic Function During de Novo Acute Respiratory Failure
N/A
Recruiting
120 participants
Started: Aug 11, 2021 · Completed: Sep 11, 2025
1 condition
1 sponsor
1 location
NCT04923906
Aumolertinib with or Without Chemotherapy As 1st Line Treatment in Locally Advanced or Metastatic Non-Small Cell Lung Cancer with Sensitizing EGFR Mutations
PHASE3
Active, not recruiting
624 participants
Started: Aug 11, 2021 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT04391465
Assessment of the Relationship Between Cerebral Blood Flow and Heart Rate
NA
Recruiting
20 participants
Started: Aug 11, 2021 · Completed: Jun 30, 2027
2 conditions
1 sponsor
1 location
NCT05072288
A Remote Physical Activity Program in the Population Suffering from Type 1 Myotonic Dystrophy
NA
Active, not recruiting
40 participants
Started: Aug 11, 2021 · Completed: Dec 1, 2026
1 condition
1 sponsor
2 locations
NCT05029583
Clinical Outcomes From Enhanced SCREENing Strategies for NASH in Type 2 Diabetes (SCREEN NASH T2D)
NA
Recruiting
5,000 participants
Started: Aug 11, 2021 · Completed: Oct 5, 2025
2 conditions
1 sponsor
1 location
NCT04745195
Complement Prospective Evaluation of Thrombotic Microangiopathy on Endothelium
N/A
Recruiting
42 participants
Started: Aug 11, 2021 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05307562
Efficacy of Respiratory Rehabilitation After COVID-19 Severe Infection
NA
Active, not recruiting
24 participants
Started: Aug 10, 2021 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05147441
Obturator Cryoneurotomy for Hip Adductor Spasticity
N/A
Recruiting
20 participants
Started: Aug 10, 2021 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT04925427
Reducing Opioid Mortality in Illinois
NA
Recruiting
1,500 participants
Started: Aug 10, 2021 · Completed: Aug 30, 2026
2 conditions
9 sponsors
5 locations
NCT04896801
MR-guided Prostate Stereotactic Body Radiotherapy in Seven Days
NA
Recruiting
132 participants
Started: Aug 10, 2021 · Completed: Feb 28, 2030
1 condition
1 sponsor
1 location
NCT05852730
Combination of Intranasal Scopolamine and Sensory Augmentation to Mitigate G-transition Induced Motion Sickness and Enhance Sensorimotor Performance
PHASE2
Recruiting
80 participants
Started: Aug 10, 2021 · Completed: Sep 30, 2026
3 conditions
2 sponsors
1 location
NCT04439968
Neonatal Brain Oxygenation Study
NA
Active, not recruiting
100 participants
Started: Aug 10, 2021 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT04830228
BIOTRONIK Dynetic-35 Stent for the Treatment of Peripheral Iliac Lesions
N/A
Active, not recruiting
160 participants
Started: Aug 10, 2021 · Completed: Feb 28, 2028
1 condition
1 sponsor
15 locations
NCT06255600
High-definition Transcranial Direct Current Stimulation and Chlorella Pyrenoidosa to Reduce Cardiovascular Risk
NA
Recruiting
60 participants
Started: Aug 10, 2021 · Completed: Jun 28, 2024
2 conditions
2 sponsors
1 location
NCT04864886
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
N/A
Recruiting
300 participants
Started: Aug 10, 2021 · Completed: Jun 30, 2027
4 conditions
1 sponsor
1 location
NCT04964115
Post Acute Sequelae of COVID-19
N/A
Active, not recruiting
500 participants
Started: Aug 10, 2021 · Completed: May 31, 2027
5 conditions
1 sponsor
1 location
NCT06025539
Animal-assisted Resilience Training for Children With Stressful Life Events or Autism Spectrum Disorder
NA
Active, not recruiting
83 participants
Started: Aug 10, 2021 · Completed: Oct 31, 2025
2 conditions
1 sponsor
1 location
NCT05005975
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
PHASE3
Recruiting
301 participants
Started: Aug 10, 2021 · Completed: Dec 31, 2027
2 conditions
1 sponsor
51 locations
NCT05011227
Camrelizumab and Chemotherapy Combined With Endoscopic Surgery for Recurrent Nasopharyngeal Carcinoma
PHASE2
Recruiting
100 participants
Started: Aug 10, 2021 · Completed: Aug 10, 2025
1 condition
2 sponsors
7 locations
NCT05055843
Novel Synthetic T2W MR Imaging and Spin Parameter Mapping Techniques for Screening Prostate Cancer
NA
Active, not recruiting
33 participants
Started: Aug 10, 2021 · Completed: Jan 31, 2027
2 conditions
1 sponsor
1 location
NCT04916132
Diabetic Nephropathy in People With Diabetes. Prevalence and Predictive Factors
N/A
Recruiting
300 participants
Started: Aug 10, 2021 · Completed: Dec 31, 2043
7 conditions
18 sponsors
13 locations
NCT04780217
Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors
PHASE1/PHASE2
Active, not recruiting
42 participants
Started: Aug 10, 2021 · Completed: Aug 31, 2025
6 conditions
1 sponsor
6 locations
NCT04897022
A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma
PHASE1
Recruiting
24 participants
Started: Aug 10, 2021 · Completed: Aug 31, 2026
1 condition
1 sponsor
7 locations
NCT05436223
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma
PHASE2
Recruiting
100 participants
Started: Aug 9, 2021 · Completed: Aug 9, 2026
1 condition
2 sponsors
1 location
NCT05024344
ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy
NA
Recruiting
128 participants
Started: Aug 9, 2021 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05392881
Interstitial Lung Disease Research Unit Biobank
N/A
Recruiting
1,000 participants
Started: Aug 9, 2021 · Completed: Mar 1, 2032
5 conditions
1 sponsor
1 location
NCT05004116
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
PHASE1/PHASE2
Recruiting
77 participants
Started: Aug 9, 2021 · Completed: Aug 31, 2028
2 conditions
1 sponsor
1 location
NCT06008249
Platform Trial to Assess the Efficacy of Multiple Drugs in Amyotrophic Lateral Sclerosis (ALS)
PHASE3
Recruiting
171 participants
Started: Aug 9, 2021 · Completed: Jun 30, 2026
1 condition
10 sponsors
13 locations
NCT05000788
Neurophysiological RCT of Qigong in Elderly With Depression
NA
Active, not recruiting
60 participants
Started: Aug 9, 2021 · Completed: Mar 31, 2026
1 condition
1 sponsor
1 location
Previous
1
More pages
1886
1887
1888
1889
1890
1891
1892
More pages
2369
Next